Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Acting Chief Counsel Choice Landa Underscores Administration Priorities

This article was originally published in The Pink Sheet Daily

Executive Summary

Michael Landa brings knowledge of foods, devices to position as FDA's top lawyer.

You may also be interested in...



FDA's New Chief Counsel Was Sharfstein's Lawyer

FDA has named Ralph Tyler, currently Insurance Commissioner of Maryland, the agency's new Chief Counsel

FDA's New Chief Counsel Was Sharfstein's Lawyer

FDA has named Ralph Tyler, currently Insurance Commissioner of Maryland, the agency's new Chief Counsel

Return to FDA: Senate Staffer Dorsey Becomes Senior Counselor To Sharfstein

Top Senate HELP Committee FDA staffer David Dorsey will return to FDA with a portfolio that includes the Office of Legislative Affairs

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069257

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel